3D Medicines
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain (NCT05265052) | 3D Medicines | 2026-12-01 |
| Study of 3D189 in Patients With Hematologic Malignancies (NCT05320809) | 3D Medicines | 2022-08-01 |
| Phase 1 Study of 3D229 in Healthy Subjects (NCT04941313) | 3D Medicines | 2021-07-27 |
Track 3D Medicines automatically
Every clearance here is in the API, with alerts when new ones post.